Author(s)

Xiaojun Liu, Lingling Tong

Corresponding Author

Lingling Tong

Abstract

To explore the clinical effect of Marvelon in the treatment of dysfunctional uterine bleeding in perimenopausal period. Ninety-nine patients with dysfunctional uterine bleeding during perimenopause were included in this study. All patients were curettaged. The patients were randomly divided into two groups. The control group was treated with progesterone after curettage, and the experimental group was treated with Marvelon. The curative effect and menstruation of the two groups were compared, and the results were analyzed statistically. The time of complete hemostasis after taking Marvelon, the amount of menstruation in the second cycle, the increase in HB before and after treatment, and the rate of irregular bleeding in patients treated with drugs were statistically significant. There was no statistically significant recurrence rate after drug withdrawal. The use of Marvelon in the treatment of women with perimenopausal dysfunctional uterine bleeding has a good effect, which is helpful for early rehabilitation of patients, and the effect is significant, and it is worthy of clinical use.

Keywords

Marvelon, Perimenopausal dysfunctional uterine bleeding, Efficacy observation